Tau Ventures
VC Fund
Palo Alto, United States
Tau Ventures is an AI-first early stage venture capital fund investing in digital health, automation (cars, drones, robots) & enterprise
- Total investments:
- 96
- Last investment:
- Lead investor:
- 4%
- Fund size:
- $41M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Tau Ventures invests in
Stages Tau Ventures invests in
Countries Tau Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Round size
- Seed
- $3M–$10M
- Series A
- $8.1M–$22M
- Series B
- $14M–$55M
Investment Focus
Industry
- Health Care 38 (40%)
- Artificial Intelligence 28 (29%)
- Software 25 (26%)
- Medical 14 (15%)
- Information Technology 13 (14%)
Stage
- Seed 46 (48%)
- Series A 22 (23%)
- Series B 7 (7%)
- Pre-Seed 5 (5%)
- Series C 5 (5%)
Country
- United States 64 (67%)
- Brazil 4 (4%)
- Japan 1 (1%)
- Canada 1 (1%)
- Israel 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Sanjay Rao
Co-Founder & Managing Partner
|
Co-Founder & Managing Partner | Total investments: 0 | Find email | |
|
Akitake Miyamoto
President and CEO
|
President and CEO | Total investments: 1 | Find email | |
Amit Garg
Venture Capitalist -- Managing Partner (Co-Founder)
|
Venture Capitalist -- Managing Partner (Co-Founder) | Total investments: 9 | Find email | |
|
Insoo Chang
Investor
|
Investor | Total investments: 0 | Find email | |
|
Sam Bogrov
Investor
|
Investor | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Kairon Health offers an AI-driven platform to optimize healthcare practice operations and improve workflow efficiency. | $5M / Seed / Sep 15, 2026 | ||
| Assort Health is building healthcare that remembers.From call center automation and form intake to referrals, document processing, outreach, and payments, we manage the entire patient journey for providers. Our platform is the most widely used AI agents platform for the patient journey, built on 180 million specialty patient interactions and amodel that handles the complexity general-purpose AI can’t.Healthcare organizations see a 5% lift in appointment volume, a 115% increase in labor capacity, and a 4.3 out of 5 patient satisfaction score.With over $222M raised from Menlo Ventures, Lightspeed, First Round Capital, Apolo Ohno, and Joe Montana, Assort is becoming the standard for how providers use AI to transform the patient journey.Learn more at assorthealth.com | $120M / Series C / Jun 24, 2026 | ||
| Tavo Biotherapeutics is a biotech company that develops injection therapies for eye diseases. | $17M / Series A / Jun 02, 2026 | ||
| AI-Enabled Coding for Medical Billing Teams | $16M / Series A / Apr 15, 2026 | ||
| ArmorCode offers an AppSecOps platform that reduces application exposure and risk for customers. Its customers use the platform for AppSec Posture, Vulnerability and Compliance Management, and DevSecOps automation. ArmorCode AppSecOps platform is delivering a 10X AppSec Force Multiplier impact to several marquee enterprises. The company wasfounded in 2020 and is based in Palo Alto, California. | $16M / Venture - Series Unknown / Mar 03, 2026 | ||
| Uptiq is a technology company that provides an AI-driven platform designed to support financial services firms with real-time analytics, risk assessment, and decision-making workflows. The company’s platform uses machine learning to process and interpret large volumes of financial data, identify trends, and generate actionable insights that helpteams evaluate credit risk, detect anomalies, and inform portfolio strategies. Its tools support integration with existing data systems and workflows, enabling users to automate data ingestion, modeling, and reporting across lending, investment, and compliance functions.Uptiq also offers customizable dashboards and APIs that help financial analysts, risk officers, and product teams operationalize insights and align them with business objectives. The company works with banks, fintechs, and financial institutions to tailor AI models and analytic frameworks to specific use cases such as credit scoring, customer lifetime value prediction, and loss forecasting. Its platform emphasizes scalable data processing and transparent model outputs to support informed decision-making in financial operations. | $25M / Series B / Feb 12, 2026 | ||
| Alaffia Health offers artificial intelligence solutions that support health plan claims operations by automating and improving clinical review workflows. Its platform uses AI agents to analyze complex medical claims data, extract structured clinical facts, and assist with payment integrity, utilization management, and appeals processing. Thecompany’s tools integrate with existing claims systems to prioritize cases, support clinician review, and help identify errors, waste, and inconsistencies before payment. Alaffia Health combines machine learning with clinician oversight to enhance accuracy in claims decisions and streamline administrative tasks for health insurance payers and related organizations. | $55M / Series B / Feb 03, 2026 | ||
| Uptiq is a technology company that provides an AI-driven platform designed to support financial services firms with real-time analytics, risk assessment, and decision-making workflows. The company’s platform uses machine learning to process and interpret large volumes of financial data, identify trends, and generate actionable insights that helpteams evaluate credit risk, detect anomalies, and inform portfolio strategies. Its tools support integration with existing data systems and workflows, enabling users to automate data ingestion, modeling, and reporting across lending, investment, and compliance functions.Uptiq also offers customizable dashboards and APIs that help financial analysts, risk officers, and product teams operationalize insights and align them with business objectives. The company works with banks, fintechs, and financial institutions to tailor AI models and analytic frameworks to specific use cases such as credit scoring, customer lifetime value prediction, and loss forecasting. Its platform emphasizes scalable data processing and transparent model outputs to support informed decision-making in financial operations. | $12M / Oct 25, 2025 | ||
| Fourier Health offers a platform that brings together clinical records from multiple sources and formats—such as PDFs, faxes, EHR data and handwritten notes—and transforms them into standardized, clinically meaningful summaries. The service supports a clinician-in-the-loop workflow so that outputs are verified and traceable back to originalsources, helping reduce data “hallucinations”. The system is configurable by specialty and use-case, enabling tailored summaries for providers in oncology, geriatrics or other areas, and it integrates with existing EHRs or document systems via APIs or Smart on FHIR apps. Fourier Health’s tools serve functions such as referral management, pre-visit readiness assessments, document labeling and triage, delivering actionable information directly into clinical workflows. | $8.4M / Seed / Oct 17, 2025 | ||
| Altitude is the AI-powered platform for the clinical workforce. | $6.9M / Seed / Oct 14, 2025 | ||
| See all 96 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Tau Ventures invest in?
Tau Ventures invests primarily in Health Care, Artificial Intelligence and Software startups, most often at Seed and Series A stage. Most of the 96 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Tau Ventures's check size?
Tau Ventures typically joins rounds of $3M–$10M at Seed, $8.1M–$22M at Series A and $14M–$55M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Tau Ventures participates in.
How do I contact Tau Ventures?
Public channels for Tau Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Tau Ventures?
The team at Tau Ventures includes Sanjay Rao (Co-Founder & Managing Partner), Akitake Miyamoto (President and CEO) and Amit Garg (Venture Capitalist -- Managing Partner (Co-Founder)), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
